BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PTEN
,
Fatty acid metabolic process
,
Obesity
,
Prostate
,
Biofuel
,
Doxorubicin
,
rs7903146
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
staurosporine aglycone
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
NUPR1
TIMP3
ATF5
MCM10
MYBL2
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
FISCHER_DREAM_TARGETS
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
KOBAYASHI_EGFR_SIGNALING_24HR_DN
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Neural 3D tissue constructs from H1 ESC-derived precursor cells treated with neurotoxic chemicals
Explore Curated Studies Results
Literature
Most Relevant Literature
Potent inhibitors of amyloid β fibrillization, 4,5-dianilinophthalimide and staurosporine aglycone, …
Synthesis of N-protected staurosporinones.
Glial cell line-derived neurotrophic factor modulates the excitability of nociceptive trigeminal gan…
Metabolic effects of ganglioside GM1 on PC12 cells at oxidative stress depend on modulation of activ…
BDNF receptor blockade hinders the beneficial effects of exercise in a rat model of Parkinson's dise…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for staurosporine aglycone
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ